Maxiflo Inhaler

Product Overview

The Maxiflo Inhaler is a respiratory medication combining Fluticasone Propionate and Formoterol Fumarate as active ingredients. This precision-engineered inhaler delivers reliable symptom relief with every administration.

Therapeutic Applications

Clinically prescribed for asthma and chronic obstructive pulmonary disease (COPD), Maxiflo Inhaler effectively manages respiratory symptoms including breathlessness, wheezing, and chronic coughing.

Mechanism of Action

Maxiflo Inhaler’s dual-component formulation provides comprehensive respiratory support:

1. Fluticasone Propionate (corticosteroid) reduces airway inflammation
2. Formoterol Fumarate (long-acting bronchodilator) relaxes airway muscles to improve airflow

Usage Instructions

For optimal results:

1. Vigorously shake the device before each use
2. Exhale fully before sealing lips around the mouthpiece
3. Activate the inhaler while inhaling deeply
4. Maintain breath-hold for 10 seconds before gradual exhalation

Strictly follow prescribed dosing frequency – never exceed medical recommendations.

Key Advantages

• Rapid symptom control for asthma and COPD
• Combined anti-inflammatory and bronchodilatory effects
• Improves pulmonary function and respiratory comfort
• Compact design for convenient daily use

Potential Adverse Effects

Some patients may experience:

• Voice changes or pharyngeal irritation
• Transient cephalalgia
• Occasional productive cough
• Mild vertigo

Persistent or severe reactions warrant medical consultation.

Important Precautions

• Not indicated for acute bronchospasm rescue
• Cardiovascular patients require special consideration
• Contraindicated for pediatric patients under 4 years
• Disclose all concurrent medications to your physician

Storage Guidelines

Maintain at room temperature (15-30°C) in low humidity. Protect from light exposure and ensure proper mouthpiece closure. Store securely to prevent accidental access by children or animals.